Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 100

Evaluating Oliceridine for Pain Relief After Orthopedic Surgery

Official title: Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · NCT06320041 · Data updated 2026-11-12

This study is testing whether a new pain medication called oliceridine can help people with moderate to severe pain after orthopedic surgery feel better compared to a standard painkiller.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment162 (estimated)
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
Academic / other
Locations1 site (Yiwu, Zhejiang)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 17, 2025
Trial IDNCT06320041 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults undergoing elective orthopedic surgery who can communicate their pain levels effectively.

Probably not a fit

Patients with advanced tumors, chronic pain conditions, or those on long-term opioid treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness and safety of oliceridine in managing moderate to severe acute pain following orthopedic surgery. Participants will be randomly assigned to receive either high-dose or low-dose oliceridine, or hydromorphone, and their pain levels will be monitored using a numerical evaluation scale. The study aims to compare the analgesic effects of these treatments to identify optimal pain management strategies. The trial is conducted under controlled conditions with standardized anesthesia protocols.

Why it matters

Potential benefit: If successful, this study could provide a more effective and safer pain management option for patients recovering from orthopedic surgery.

How similar studies have gone: Previous studies have shown promise in using oliceridine for pain management, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. elective orthopedic surgery under general anesthesia.
2. The patient can communicate normally and has the correct expression of pain

Exclusion Criteria:

1. Patients with advanced tumor
2. Other acute and chronic pain conditions are present
3. Severely obese (30 kg/m2)
4. Pregnant or lactating women
5. Allergy to opioids
6. Sleep apnea syndrome
7. Long-term opioid treatment
8. Patients with mental and nervous system diseases, gastrointestinal obstruction, chronic obstructive pulmonary disease or pulmonary heart disease, cardiovascular disease
9. Abnormal liver function during screening
10. Abnormal renal function during screening

Where it's running

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine
    Yiwu, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.